APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Colloids (Blood Plasma)

Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.

Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.

Selected research

Market Outlook & Growth Opportunities

Global Colloids (Blood Plasma) Market Outlook and Growth Opportunities 2026

Report ID 17397964049 January 2026218 pages

Choose your research edition.

Industry ResearchColloids (Blood Plasma) Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Colloids (Blood Plasma) Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Colloids (Blood Plasma) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Colloids (Blood Plasma) Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Colloids (Blood Plasma) Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.

Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.

North America is the largest Colloids (Blood Plasma) market with about 33% market share. Europe is follower, accounting for about 28% market share.

Read the full market overview

The key players are CSL Behring, Baxter, Grifols, Octapharma, Kedrion, Shanghai Raas, CTBB, Hualan Bio, Rongsheng Pharmaceutical, Boya Rongsheng, B. Braun Medical, Fresenius Kabi, HOSPIRA, Axa parenterals, Fresenius Kabi(China), CR Double-Crane, Kelun Group, Shandong Qidu Pharmaceutical, Shandong Hualu Pharmaceutical, Minsheng Pharma, Kanglepharm etc. Top 3 companies occupied about 46% market share.

This report provides an overview of the global Colloids (Blood Plasma) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Colloids (Blood Plasma) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Colloids (Blood Plasma) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Colloids (Blood Plasma) market size, projected growth trends, production technologies, key applications, and end-use industries.

Colloids (Blood Plasma) Segment by Company

CSL Behring

Baxter

Grifols

Octapharma

Kedrion

Shanghai Raas

CTBB

Hualan Bio

Rongsheng Pharmaceutical

Boya Rongsheng

B. Braun Medical

Fresenius Kabi

HOSPIRA

Axa parenterals

Fresenius Kabi (China)

CR Double-Crane

Kelun Group

Shandong Qidu Pharmaceutical

Shandong Hualu Pharmaceutical

Minsheng Pharma

Kanglepharm

Colloids (Blood Plasma) Segment by Type

Natural Type Colloids (Blood Plasma)

Synthetic Type Colloids (Blood Plasma)

Colloids (Blood Plasma) Segment by Application

Extensive Burns

Massive Blood or Plasma Loss

Hypovolemic Shock

Others

Colloids (Blood Plasma) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Colloids (Blood Plasma) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Colloids (Blood Plasma) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Colloids (Blood Plasma) significant trends, drivers, influence factors in global and regions.

6. To analyze Colloids (Blood Plasma) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Colloids (Blood Plasma) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Colloids (Blood Plasma) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Colloids (Blood Plasma).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Colloids (Blood Plasma) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Colloids (Blood Plasma) industry.

Chapter 3: Detailed analysis of Colloids (Blood Plasma) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Colloids (Blood Plasma) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Colloids (Blood Plasma) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Colloids (Blood Plasma) Industry Trends Table 2. Colloids (Blood Plasma) Industry Drivers Table 3. Colloids (Blood Plasma) Industry Opportunities and Challenges Table 4. Colloids (Blood Plasma) Industry Restraints Table 5. Global Colloids (Blood Plasma) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Colloids (Blood Plasma) Revenue Share by Company (2021-2026) Table 7. Global Colloids (Blood Plasma) Sales Volume by Company (MT) & (2021-2026) Table 8. Global Colloids (Blood Plasma) Sales Volume Share by Company (2021-2026) Table 9. Global Colloids (Blood Plasma) Average Price (USD/Kg) of Company (2021-2026) Table 10. Global Colloids (Blood Plasma) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Colloids (Blood Plasma) Key Company Manufacturing Base & Headquarters Table 12. Global Colloids (Blood Plasma) Company, Product Type & Application Table 13. Global Colloids (Blood Plasma) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Colloids (Blood Plasma) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Natural Type Colloids (Blood Plasma) Table 18. Significant Companies of Synthetic Type Colloids (Blood Plasma) Table 19. Global Colloids (Blood Plasma) Sales Volume by Type 2021 VS 2025 VS 2032 (MT) Table 20. Global Colloids (Blood Plasma) Sales Volume by Type (2021-2026) & (MT) Table 21. Global Colloids (Blood Plasma) Sales Volume by Type (2027-2032) & (MT) Table 22. Global Colloids (Blood Plasma) Sales Volume Share by Type (2021-2026) Table 23. Global Colloids (Blood Plasma) Sales Volume Share by Type (2027-2032) Table 24. Global Colloids (Blood Plasma) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Colloids (Blood Plasma) Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Colloids (Blood Plasma) Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Colloids (Blood Plasma) Sales Value Share by Type (2021-2026) Table 28. Global Colloids (Blood Plasma) Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Extensive Burns Table 30. Significant Companies of Massive Blood or Plasma Loss Table 31. Significant Companies of Hypovolemic Shock Table 32. Significant Companies of Others Table 33. Global Colloids (Blood Plasma) Sales Volume by Application 2021 VS 2025 VS 2032 (MT) Table 34. Global Colloids (Blood Plasma) Sales Volume by Application (2021-2026) & (MT) Table 35. Global Colloids (Blood Plasma) Sales Volume by Application (2027-2032) & (MT) Table 36. Global Colloids (Blood Plasma) Sales Volume Share by Application (2021-2026) Table 37. Global Colloids (Blood Plasma) Sales Volume Share by Application (2027-2032) Table 38. Global Colloids (Blood Plasma) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Colloids (Blood Plasma) Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Colloids (Blood Plasma) Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Colloids (Blood Plasma) Sales Value Share by Application (2021-2026) Table 42. Global Colloids (Blood Plasma) Sales Value Share by Application (2027-2032) Table 43. Global Colloids (Blood Plasma) Sales by Region: 2021 VS 2025 VS 2032 (MT) Table 44. Global Colloids (Blood Plasma) Sales by Region (2021-2026) & (MT) Table 45. Global Colloids (Blood Plasma) Sales Market Share by Region (2021-2026) Table 46. Global Colloids (Blood Plasma) Sales by Region (2027-2032) & (MT) Table 47. Global Colloids (Blood Plasma) Sales Market Share by Region (2027-2032) Table 48. Global Colloids (Blood Plasma) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Colloids (Blood Plasma) Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Colloids (Blood Plasma) Sales Value Share by Region (2021-2026) Table 51. Global Colloids (Blood Plasma) Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Colloids (Blood Plasma) Sales Value Share by Region (2027-2032) Table 53. Global Colloids (Blood Plasma) Market Average Price (USD/Kg) by Region (2021-2026) Table 54. Global Colloids (Blood Plasma) Market Average Price (USD/Kg) by Region (2027-2032) Table 55. Global Colloids (Blood Plasma) Sales by Country: 2021 VS 2025 VS 2032 (MT) Table 56. Global Colloids (Blood Plasma) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Colloids (Blood Plasma) Sales by Country (2021-2026) & (MT) Table 58. Global Colloids (Blood Plasma) Sales Market Share by Country (2021-2026) Table 59. Global Colloids (Blood Plasma) Sales by Country (2027-2032) & (MT) Table 60. Global Colloids (Blood Plasma) Sales Market Share by Country (2027-2032) Table 61. Global Colloids (Blood Plasma) Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Colloids (Blood Plasma) Sales Value Market Share by Country (2021-2026) Table 63. Global Colloids (Blood Plasma) Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Colloids (Blood Plasma) Sales Value Market Share by Country (2027-2032) Table 65. CSL Behring Company Information Table 66. CSL Behring Business Overview Table 67. CSL Behring Colloids (Blood Plasma) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 68. CSL Behring Colloids (Blood Plasma) Product Portfolio Table 69. CSL Behring Recent Development Table 70. Baxter Company Information Table 71. Baxter Business Overview Table 72. Baxter Colloids (Blood Plasma) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 73. Baxter Colloids (Blood Plasma) Product Portfolio Table 74. Baxter Recent Development Table 75. Grifols Company Information Table 76. Grifols Business Overview Table 77. Grifols Colloids (Blood Plasma) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 78. Grifols Colloids (Blood Plasma) Product Portfolio Table 79. Grifols Recent Development Table 80. Octapharma Company Information Table 81. Octapharma Business Overview Table 82. Octapharma Colloids (Blood Plasma) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 83. Octapharma Colloids (Blood Plasma) Product Portfolio Table 84. Octapharma Recent Development Table 85. Kedrion Company Information Table 86. Kedrion Business Overview Table 87. Kedrion Colloids (Blood Plasma) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 88. Kedrion Colloids (Blood Plasma) Product Portfolio Table 89. Kedrion Recent Development Table 90. Shanghai Raas Company Information Table 91. Shanghai Raas Business Overview Table 92. Shanghai Raas Colloids (Blood Plasma) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 93. Shanghai Raas Colloids (Blood Plasma) Product Portfolio Table 94. Shanghai Raas Recent Development Table 95. CTBB Company Information Table 96. CTBB Business Overview Table 97. CTBB Colloids (Blood Plasma) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 98. CTBB Colloids (Blood Plasma) Product Portfolio Table 99. CTBB Recent Development Table 100. Hualan Bio Company Information Table 101. Hualan Bio Business Overview Table 102. Hualan Bio Colloids (Blood Plasma) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 103. Hualan Bio Colloids (Blood Plasma) Product Portfolio Table 104. Hualan Bio Recent Development Table 105. Rongsheng Pharmaceutical Company Information Table 106. Rongsheng Pharmaceutical Business Overview Table 107. Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 108. Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Portfolio Table 109. Rongsheng Pharmaceutical Recent Development Table 110. Boya Rongsheng Company Information Table 111. Boya Rongsheng Business Overview Table 112. Boya Rongsheng Colloids (Blood Plasma) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 113. Boya Rongsheng Colloids (Blood Plasma) Product Portfolio Table 114. Boya Rongsheng Recent Development Table 115. B. Braun Medical Company Information Table 116. B. Braun Medical Business Overview Table 117. B. Braun Medical Colloids (Blood Plasma) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 118. B. Braun Medical Colloids (Blood Plasma) Product Portfolio Table 119. B. Braun Medical Recent Development Table 120. Fresenius Kabi Company Information Table 121. Fresenius Kabi Business Overview Table 122. Fresenius Kabi Colloids (Blood Plasma) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 123. Fresenius Kabi Colloids (Blood Plasma) Product Portfolio Table 124. Fresenius Kabi Recent Development Table 125. HOSPIRA Company Information Table 126. HOSPIRA Business Overview Table 127. HOSPIRA Colloids (Blood Plasma) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 128. HOSPIRA Colloids (Blood Plasma) Product Portfolio Table 129. HOSPIRA Recent Development Table 130. Axa parenterals Company Information Table 131. Axa parenterals Business Overview Table 132. Axa parenterals Colloids (Blood Plasma) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 133. Axa parenterals Colloids (Blood Plasma) Product Portfolio Table 134. Axa parenterals Recent Development Table 135. Fresenius Kabi (China) Company Information Table 136. Fresenius Kabi (China) Business Overview Table 137. Fresenius Kabi (China) Colloids (Blood Plasma) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 138. Fresenius Kabi (China) Colloids (Blood Plasma) Product Portfolio Table 139. Fresenius Kabi (China) Recent Development Table 140. CR Double-Crane Company Information Table 141. CR Double-Crane Business Overview Table 142. CR Double-Crane Colloids (Blood Plasma) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 143. CR Double-Crane Colloids (Blood Plasma) Product Portfolio Table 144. CR Double-Crane Recent Development Table 145. Kelun Group Company Information Table 146. Kelun Group Business Overview Table 147. Kelun Group Colloids (Blood Plasma) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 148. Kelun Group Colloids (Blood Plasma) Product Portfolio Table 149. Kelun Group Recent Development Table 150. Shandong Qidu Pharmaceutical Company Information Table 151. Shandong Qidu Pharmaceutical Business Overview Table 152. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 153. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Portfolio Table 154. Shandong Qidu Pharmaceutical Recent Development Table 155. Shandong Hualu Pharmaceutical Company Information Table 156. Shandong Hualu Pharmaceutical Business Overview Table 157. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 158. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Portfolio Table 159. Shandong Hualu Pharmaceutical Recent Development Table 160. Minsheng Pharma Company Information Table 161. Minsheng Pharma Business Overview Table 162. Minsheng Pharma Colloids (Blood Plasma) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 163. Minsheng Pharma Colloids (Blood Plasma) Product Portfolio Table 164. Minsheng Pharma Recent Development Table 165. Kanglepharm Company Information Table 166. Kanglepharm Business Overview Table 167. Kanglepharm Colloids (Blood Plasma) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 168. Kanglepharm Colloids (Blood Plasma) Product Portfolio Table 169. Kanglepharm Recent Development Table 170. Key Raw Materials Table 171. Raw Materials Key Suppliers Table 172. Colloids (Blood Plasma) Distributors List Table 173. Colloids (Blood Plasma) Customers List Table 174. Research Programs/Design for This Report Table 175. Authors List of This Report Table 176. Secondary Sources Table 177. Primary Sources List of Figures Figure 1. Colloids (Blood Plasma) Product Image Figure 2. Global Colloids (Blood Plasma) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Colloids (Blood Plasma) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Colloids (Blood Plasma) Sales (2021-2032) & (MT) Figure 5. Global Colloids (Blood Plasma) Sales Average Price (USD/Kg) & (2021-2032) Figure 6. Global Colloids (Blood Plasma) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Natural Type Colloids (Blood Plasma) Image Figure 10. Synthetic Type Colloids (Blood Plasma) Image Figure 11. Global Colloids (Blood Plasma) Sales Volume by Type (2021 VS 2025 VS 2032) & (MT) Figure 12. Global Colloids (Blood Plasma) Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Colloids (Blood Plasma) Sales Volume Share by Type (2021-2032) Figure 14. Global Colloids (Blood Plasma) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Colloids (Blood Plasma) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Colloids (Blood Plasma) Sales Value Share by Type (2021-2032) Figure 17. Extensive Burns Image Figure 18. Massive Blood or Plasma Loss Image Figure 19. Hypovolemic Shock Image Figure 20. Others Image Figure 21. Global Colloids (Blood Plasma) Sales Volume by Application (2021 VS 2025 VS 2032) & (MT) Figure 22. Global Colloids (Blood Plasma) Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Colloids (Blood Plasma) Sales Volume Share by Application (2021-2032) Figure 24. Global Colloids (Blood Plasma) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Colloids (Blood Plasma) Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Colloids (Blood Plasma) Sales Value Share by Application (2021-2032) Figure 27. Global Colloids (Blood Plasma) Sales by Region: 2021 VS 2025 VS 2032 (MT) Figure 28. Global Colloids (Blood Plasma) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Colloids (Blood Plasma) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Colloids (Blood Plasma) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Colloids (Blood Plasma) Sales Value (2021-2032) & (US$ Million) Figure 32. North America Colloids (Blood Plasma) Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Colloids (Blood Plasma) Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Colloids (Blood Plasma) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Colloids (Blood Plasma) Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Colloids (Blood Plasma) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Colloids (Blood Plasma) Sales Value (2021-2032) & (US$ Million) Figure 38. South America Colloids (Blood Plasma) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Colloids (Blood Plasma) Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Colloids (Blood Plasma) Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Colloids (Blood Plasma) Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Colloids (Blood Plasma) Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Natural Type Colloids (Blood Plasma)
  • Synthetic Type Colloids (Blood Plasma)
Applications
  • Extensive Burns
  • Massive Blood or Plasma Loss
  • Hypovolemic Shock
  • Others
Companies covered
  • CSL Behring
  • Baxter
  • Grifols
  • Octapharma
  • Kedrion
  • Shanghai Raas
  • CTBB
  • Hualan Bio
  • Rongsheng Pharmaceutical
  • Boya Rongsheng
  • B. Braun Medical
  • Fresenius Kabi
  • HOSPIRA
  • Axa parenterals
  • Fresenius Kabi (China)
  • CR Double-Crane
  • Kelun Group
  • Shandong Qidu Pharmaceutical
  • Shandong Hualu Pharmaceutical
  • Minsheng Pharma
  • Kanglepharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Colloids (Blood Plasma) Sales Value (2021-2032)
  4. 1.2.2 Global Colloids (Blood Plasma) Sales Volume (2021-2032)
  5. 1.2.3 Global Colloids (Blood Plasma) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Colloids (Blood Plasma) Market Dynamics
  1. 2.1 Colloids (Blood Plasma) Industry Trends
  2. 2.2 Colloids (Blood Plasma) Industry Drivers
  3. 2.3 Colloids (Blood Plasma) Industry Opportunities and Challenges
  4. 2.4 Colloids (Blood Plasma) Industry Restraints
3 Colloids (Blood Plasma) Market by Company
  1. 3.1 Global Colloids (Blood Plasma) Company Revenue Ranking in 2025
  2. 3.2 Global Colloids (Blood Plasma) Revenue by Company (2021-2026)
  3. 3.3 Global Colloids (Blood Plasma) Sales Volume by Company (2021-2026)
  4. 3.4 Global Colloids (Blood Plasma) Average Price by Company (2021-2026)
  5. 3.5 Global Colloids (Blood Plasma) Company Ranking (2024-2026)
  6. 3.6 Global Colloids (Blood Plasma) Company Manufacturing Base and Headquarters
  7. 3.7 Global Colloids (Blood Plasma) Company Product Type and Application
  8. 3.8 Global Colloids (Blood Plasma) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Colloids (Blood Plasma) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Colloids (Blood Plasma) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Colloids (Blood Plasma) Market by Type
  1. 4.1 Colloids (Blood Plasma) Type Introduction
  2. 4.1.1 Natural Type Colloids (Blood Plasma)
  3. 4.1.2 Synthetic Type Colloids (Blood Plasma)
  4. 4.2 Global Colloids (Blood Plasma) Sales Volume by Type
  5. 4.2.1 Global Colloids (Blood Plasma) Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Colloids (Blood Plasma) Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Colloids (Blood Plasma) Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Colloids (Blood Plasma) Sales Value by Type
  9. 4.3.1 Global Colloids (Blood Plasma) Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Colloids (Blood Plasma) Sales Value by Type (2021-2032)
  11. 4.3.3 Global Colloids (Blood Plasma) Sales Value Share by Type (2021-2032)
5 Colloids (Blood Plasma) Market by Application
  1. 5.1 Colloids (Blood Plasma) Application Introduction
  2. 5.1.1 Extensive Burns
  3. 5.1.2 Massive Blood or Plasma Loss
  4. 5.1.3 Hypovolemic Shock
  5. 5.1.4 Others
  6. 5.2 Global Colloids (Blood Plasma) Sales Volume by Application
  7. 5.2.1 Global Colloids (Blood Plasma) Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Colloids (Blood Plasma) Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Colloids (Blood Plasma) Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Colloids (Blood Plasma) Sales Value by Application
  11. 5.3.1 Global Colloids (Blood Plasma) Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Colloids (Blood Plasma) Sales Value by Application (2021-2032)
  13. 5.3.3 Global Colloids (Blood Plasma) Sales Value Share by Application (2021-2032)
6 Colloids (Blood Plasma) Regional Sales and Value Analysis
  1. 6.1 Global Colloids (Blood Plasma) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Colloids (Blood Plasma) Sales by Region (2021-2032)
  3. 6.2.1 Global Colloids (Blood Plasma) Sales by Region: 2021-2026
  4. 6.2.2 Global Colloids (Blood Plasma) Sales by Region (2027-2032)
  5. 6.3 Global Colloids (Blood Plasma) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Colloids (Blood Plasma) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Colloids (Blood Plasma) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Colloids (Blood Plasma) Sales Value by Region (2027-2032)
  9. 6.5 Global Colloids (Blood Plasma) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Colloids (Blood Plasma) Sales Value (2021-2032)
  12. 6.6.2 North America Colloids (Blood Plasma) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Colloids (Blood Plasma) Sales Value (2021-2032)
  15. 6.7.2 Europe Colloids (Blood Plasma) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Colloids (Blood Plasma) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Colloids (Blood Plasma) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Colloids (Blood Plasma) Sales Value (2021-2032)
  21. 6.9.2 South America Colloids (Blood Plasma) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Colloids (Blood Plasma) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Colloids (Blood Plasma) Sales Value Share by Country, 2025 VS 2032
7 Colloids (Blood Plasma) Country-level Sales and Value Analysis
  1. 7.1 Global Colloids (Blood Plasma) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Colloids (Blood Plasma) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Colloids (Blood Plasma) Sales by Country (2021-2032)
  4. 7.3.1 Global Colloids (Blood Plasma) Sales by Country (2021-2026)
  5. 7.3.2 Global Colloids (Blood Plasma) Sales by Country (2027-2032)
  6. 7.4 Global Colloids (Blood Plasma) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Colloids (Blood Plasma) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Colloids (Blood Plasma) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Colloids (Blood Plasma) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Colloids (Blood Plasma) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Colloids (Blood Plasma) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CSL Behring
  2. 8.1.1 CSL Behring Company Information
  3. 8.1.2 CSL Behring Business Overview
  4. 8.1.3 CSL Behring Colloids (Blood Plasma) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 CSL Behring Colloids (Blood Plasma) Product Portfolio
  6. 8.1.5 CSL Behring Recent Developments
  7. 8.2 Baxter
  8. 8.2.1 Baxter Company Information
  9. 8.2.2 Baxter Business Overview
  10. 8.2.3 Baxter Colloids (Blood Plasma) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Baxter Colloids (Blood Plasma) Product Portfolio
  12. 8.2.5 Baxter Recent Developments
  13. 8.3 Grifols
  14. 8.3.1 Grifols Company Information
  15. 8.3.2 Grifols Business Overview
  16. 8.3.3 Grifols Colloids (Blood Plasma) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Grifols Colloids (Blood Plasma) Product Portfolio
  18. 8.3.5 Grifols Recent Developments
  19. 8.4 Octapharma
  20. 8.4.1 Octapharma Company Information
  21. 8.4.2 Octapharma Business Overview
  22. 8.4.3 Octapharma Colloids (Blood Plasma) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Octapharma Colloids (Blood Plasma) Product Portfolio
  24. 8.4.5 Octapharma Recent Developments
  25. 8.5 Kedrion
  26. 8.5.1 Kedrion Company Information
  27. 8.5.2 Kedrion Business Overview
  28. 8.5.3 Kedrion Colloids (Blood Plasma) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Kedrion Colloids (Blood Plasma) Product Portfolio
  30. 8.5.5 Kedrion Recent Developments
  31. 8.6 Shanghai Raas
  32. 8.6.1 Shanghai Raas Company Information
  33. 8.6.2 Shanghai Raas Business Overview
  34. 8.6.3 Shanghai Raas Colloids (Blood Plasma) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai Raas Colloids (Blood Plasma) Product Portfolio
  36. 8.6.5 Shanghai Raas Recent Developments
  37. 8.7 CTBB
  38. 8.7.1 CTBB Company Information
  39. 8.7.2 CTBB Business Overview
  40. 8.7.3 CTBB Colloids (Blood Plasma) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 CTBB Colloids (Blood Plasma) Product Portfolio
  42. 8.7.5 CTBB Recent Developments
  43. 8.8 Hualan Bio
  44. 8.8.1 Hualan Bio Company Information
  45. 8.8.2 Hualan Bio Business Overview
  46. 8.8.3 Hualan Bio Colloids (Blood Plasma) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Hualan Bio Colloids (Blood Plasma) Product Portfolio
  48. 8.8.5 Hualan Bio Recent Developments
  49. 8.9 Rongsheng Pharmaceutical
  50. 8.9.1 Rongsheng Pharmaceutical Company Information
  51. 8.9.2 Rongsheng Pharmaceutical Business Overview
  52. 8.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Portfolio
  54. 8.9.5 Rongsheng Pharmaceutical Recent Developments
  55. 8.10 Boya Rongsheng
  56. 8.10.1 Boya Rongsheng Company Information
  57. 8.10.2 Boya Rongsheng Business Overview
  58. 8.10.3 Boya Rongsheng Colloids (Blood Plasma) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Boya Rongsheng Colloids (Blood Plasma) Product Portfolio
  60. 8.10.5 Boya Rongsheng Recent Developments
  61. 8.11 B. Braun Medical
  62. 8.11.1 B. Braun Medical Company Information
  63. 8.11.2 B. Braun Medical Business Overview
  64. 8.11.3 B. Braun Medical Colloids (Blood Plasma) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 B. Braun Medical Colloids (Blood Plasma) Product Portfolio
  66. 8.11.5 B. Braun Medical Recent Developments
  67. 8.12 Fresenius Kabi
  68. 8.12.1 Fresenius Kabi Company Information
  69. 8.12.2 Fresenius Kabi Business Overview
  70. 8.12.3 Fresenius Kabi Colloids (Blood Plasma) Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Fresenius Kabi Colloids (Blood Plasma) Product Portfolio
  72. 8.12.5 Fresenius Kabi Recent Developments
  73. 8.13 HOSPIRA
  74. 8.13.1 HOSPIRA Company Information
  75. 8.13.2 HOSPIRA Business Overview
  76. 8.13.3 HOSPIRA Colloids (Blood Plasma) Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 HOSPIRA Colloids (Blood Plasma) Product Portfolio
  78. 8.13.5 HOSPIRA Recent Developments
  79. 8.14 Axa parenterals
  80. 8.14.1 Axa parenterals Company Information
  81. 8.14.2 Axa parenterals Business Overview
  82. 8.14.3 Axa parenterals Colloids (Blood Plasma) Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Axa parenterals Colloids (Blood Plasma) Product Portfolio
  84. 8.14.5 Axa parenterals Recent Developments
  85. 8.15 Fresenius Kabi (China)
  86. 8.15.1 Fresenius Kabi (China) Company Information
  87. 8.15.2 Fresenius Kabi (China) Business Overview
  88. 8.15.3 Fresenius Kabi (China) Colloids (Blood Plasma) Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Fresenius Kabi (China) Colloids (Blood Plasma) Product Portfolio
  90. 8.15.5 Fresenius Kabi (China) Recent Developments
  91. 8.16 CR Double-Crane
  92. 8.16.1 CR Double-Crane Company Information
  93. 8.16.2 CR Double-Crane Business Overview
  94. 8.16.3 CR Double-Crane Colloids (Blood Plasma) Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 CR Double-Crane Colloids (Blood Plasma) Product Portfolio
  96. 8.16.5 CR Double-Crane Recent Developments
  97. 8.17 Kelun Group
  98. 8.17.1 Kelun Group Company Information
  99. 8.17.2 Kelun Group Business Overview
  100. 8.17.3 Kelun Group Colloids (Blood Plasma) Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Kelun Group Colloids (Blood Plasma) Product Portfolio
  102. 8.17.5 Kelun Group Recent Developments
  103. 8.18 Shandong Qidu Pharmaceutical
  104. 8.18.1 Shandong Qidu Pharmaceutical Company Information
  105. 8.18.2 Shandong Qidu Pharmaceutical Business Overview
  106. 8.18.3 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
  108. 8.18.5 Shandong Qidu Pharmaceutical Recent Developments
  109. 8.19 Shandong Hualu Pharmaceutical
  110. 8.19.1 Shandong Hualu Pharmaceutical Company Information
  111. 8.19.2 Shandong Hualu Pharmaceutical Business Overview
  112. 8.19.3 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
  114. 8.19.5 Shandong Hualu Pharmaceutical Recent Developments
  115. 8.20 Minsheng Pharma
  116. 8.20.1 Minsheng Pharma Company Information
  117. 8.20.2 Minsheng Pharma Business Overview
  118. 8.20.3 Minsheng Pharma Colloids (Blood Plasma) Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Minsheng Pharma Colloids (Blood Plasma) Product Portfolio
  120. 8.20.5 Minsheng Pharma Recent Developments
  121. 8.21 Kanglepharm
  122. 8.21.1 Kanglepharm Company Information
  123. 8.21.2 Kanglepharm Business Overview
  124. 8.21.3 Kanglepharm Colloids (Blood Plasma) Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Kanglepharm Colloids (Blood Plasma) Product Portfolio
  126. 8.21.5 Kanglepharm Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Colloids (Blood Plasma) Value Chain Analysis
  2. 9.1.1 Colloids (Blood Plasma) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Colloids (Blood Plasma) Sales Mode & Process
  6. 9.2 Colloids (Blood Plasma) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Colloids (Blood Plasma) Distributors
  9. 9.2.3 Colloids (Blood Plasma) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst